135 related articles for article (PubMed ID: 6817959)
1. [The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
Marzetti L; Marcellini G; Midulla C
Clin Ter; 1982 Nov; 103(4):405-9. PubMed ID: 6817959
[No Abstract] [Full Text] [Related]
2. [Lithium carbonate in prevention of leukopenia/caused by antineoplastic drugs].
Orlando S; Baroni MC; Crotti G; Mineo F; Capra A; Coiro V; Delsignore R
G Clin Med; 1981 May; 62(5):351-9. PubMed ID: 6791980
[No Abstract] [Full Text] [Related]
3. [Lithium carbonate--a preventive agent against leukopenia during cytostatic therapy].
Lahousen M; Pickel H; Haas J
Wien Klin Wochenschr; 1984 Oct; 96(19):739-41. PubMed ID: 6441351
[TBL] [Abstract][Full Text] [Related]
4. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.
Glass A; Wieand HS; Fisher B; Redmond C; Lerner H; Wolter J; Shibata H; Plotkin D; Foster R; Margolese R; Wolmark N
Cancer Treat Rep; 1981; 65(5-6):363-76. PubMed ID: 7016322
[TBL] [Abstract][Full Text] [Related]
5. Complications and toxic manifestations of surgical adjuvant chemotherapy for breast cancer.
Cohn I
Surg Gynecol Obstet; 1968 Dec; 127(6):1201-9. PubMed ID: 4973320
[No Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
7. [Our experience with cyclophosphamide, methotrexate and 5-fluorouracil in the postoperative treatment of breast carcinoma].
Cavallaro V; Grasso F; Minutolo V; Turco F; Narbone G; Consoli A
Chir Ital; 1982 Apr; 34(2):292-306. PubMed ID: 6896473
[No Abstract] [Full Text] [Related]
8. [Medical treatment of early breast cancer: chemotherapy].
Ejlertsen B; Kamby C
Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
[TBL] [Abstract][Full Text] [Related]
9. [Dose-effect relation in therapy of cytostatic-induced leukopenia with lithium carbonate].
Burdach SE; Godehardt E; Hesse C
Klin Padiatr; 1985; 197(3):253-7. PubMed ID: 3925216
[TBL] [Abstract][Full Text] [Related]
10. Life with cytostatic drugs.
Van Dam FS; Linssen AC; Engelsman E; van Benthem J; Hanewald GJ
Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892
[No Abstract] [Full Text] [Related]
11. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
12. [Iatrogenic diabetic coma. Contribution to adverse effects of cytostatic therapy].
Barb U; Vielberg H
Strahlentherapie; 1973 Feb; 145(2):234-7. PubMed ID: 4694661
[No Abstract] [Full Text] [Related]
13. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
15. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells.
Kopjar N; Milas I; Garaj-Vrhovac V; Gamulin M
Clin Exp Med; 2006 Dec; 6(4):177-90. PubMed ID: 17191110
[TBL] [Abstract][Full Text] [Related]
16. [Lithium carbonate treatment of neutropenia caused by cancer chemotherapy].
Krzakowski M; Roszkowski K; Nowakowski W
Wiad Lek; 1983 Jan; 36(2):95-9. PubMed ID: 6407209
[No Abstract] [Full Text] [Related]
17. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
Sautter-Bihl ML; Sauer R
Strahlenther Onkol; 2007 Jul; 183(7):357-9. PubMed ID: 17609867
[No Abstract] [Full Text] [Related]
18. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
19. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
20. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
Sack H
Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
